Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 632 of 5804
-
Fish allergy cure? new trial tests codfish therapy in kids
Disease control OngoingAt present there is no cure for food allergy. People with a food allergy need to avoid the food they are allergic to in order to stay safe, but we know that accidental exposure is common. Researchers have begun to look at the effectiveness of 'oral immunotherapy' as a treatment f…
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New device aims to suck out dangerous blood clots, sparing patients from Long-Term leg damage
Disease control Recruiting nowThis study is a prospective, multicenter, randomized controlled trial of an interventional strategy using the ClotTriever System to achieve and maintain vessel patency (ClotTriever Intervention Arm) versus conservative medical management using anticoagulation therapy alone (Conse…
Phase: NA • Sponsor: Inari Medical • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New hope for hard-to-treat stomach cancer? drug duo targets MET gene
Disease control Recruiting nowFor patients who failed primary chemotherapy with MET amplification, The efficacy and safety of the chemotherapy are evaluated by using dervalumab and saboritinib in combination.
Phase: PHASE2 • Sponsor: Jeeyun Lee • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New drug combo aims to wipe out hidden myeloma cells after transplant
Disease control Recruiting nowThis is a phase II study where patients will undergo isatuximab and lenalidomide maintenance if they are MRD-positive after Autologous Stem Cell Transplant (ASCT)
Phase: PHASE2 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New hope for rare, aggressive blood cancer: 3-Drug cocktail targets richter transformation
Disease control Recruiting nowThis phase II trial tests whether acalabrutinib, venetoclax, and durvalumab work in treating patients with Richter transformation from chronic lymphocytic leukemia or small lymphocytic lymphoma. Richter transformation is a rare condition in which chronic lymphocytic leukemia or s…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New drug batoclimab aims to reduce eye bulging in thyroid eye disease
Disease control CompletedTo evaluate the efficacy of batoclimab 680 milligrams (mg) subcutaneous (SC) once a week (QW) for 12 weeks followed by 340 mg SC QW for 12 weeks versus placebo on proptosis responder rate at Week 24.
Phase: PHASE3 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Green tea extract may boost fertility in women with fibroids
Disease control OngoingThe objective of this study is to determine the effect of low caffeine green tea extract containing 45% epigallocatechin gallate (EGCG) on fibroids and subsequent pregnancy and live births in women seeking fertility treatment. The population will consist of 50 women desirous of …
Phase: PHASE3 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New pill shows promise against tough lung cancer in early trial
Disease control OngoingThe primary objective is to evaluate the efficacy/safety of lazertinib and to explore the resistance mechanism of lazertinib as first-line in patients with NSCLC harboring activating EGFR mutations.
Phase: PHASE2 • Sponsor: Se-Hoon Lee • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Sound waves open brain barrier to attack deadly childhood tumor
Disease control OngoingThe purpose of this study is to evaluate the safety and efficacy of targeted blood brain barrier disruption with Exablate Model 4000 Type 2.0/2.1 in combination with Doxorubicin therapy for the treatment of DIPG in pediatric patients
Phase: PHASE1, PHASE2 • Sponsor: InSightec • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Badminton battles phone addiction: study tests sport as digital detox for teens
Disease control CompletedThe global surge in smartphone addiction (SA) represents a critical biopsychosocial risk for adolescents. This study evaluated the efficacy of a 12-week structured badminton intervention in alleviating SA among high school students and explored the psychosocial mechanisms underly…
Phase: NA • Sponsor: Zonguldak Bulent Ecevit University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New hope for NASH: drug targets liver scarring in advanced disease
Disease control OngoingThe purpose of this study is to measure improvements in liver fibrosis and inflammation with GSK4532990 compared with placebo in participants with NASH and advanced fibrosis on biopsy (F3 or F4). The study duration will be up to 76 weeks including the screening period. The treatm…
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Heart surgery drug showdown: can vasopressin save more kidneys?
Disease control OngoingThis is a randomized, double blind, multicenter study following surgery with extracorporeal circulation to compare blood pressure optimization with vasopressin versus noradrenaline. It is planned to include 840 patients in order to have 420 patients with vasoplegic syndrome. The…
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Can an arthritis drug tame deadly dengue inflammation?
Disease control OngoingThis study aims to evaluate the effect of anakinra in dengue patients with hyperinflammation as compared to placebo Primary Objective: To evaluate the efficacy of Anakinra in moderate-severe dengue patients with hyperinflammation. Secondary Objectives: * To assess the safety …
Phase: PHASE2 • Sponsor: Oxford University Clinical Research Unit, Vietnam • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Blood test may predict pancreatic cancer recurrence before scans
Knowledge-focused Recruiting nowThe goal of this clinical trial is to investigate if plasma ctDNA and eccDNA before resection for suspicion of pancreatic ductal adenocarcinoma (PDAC) can predict early recurrence and overall survival, and to investigate if plasma ctDNA combined with CT scan and endoscopic ultras…
Phase: NA • Sponsor: Copenhagen University Hospital at Herlev • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Radiation boost may improve immunotherapy for esophageal cancer
Disease control Recruiting nowSCR-ESCC-01 is a multicenter, randomized, phase II study aiming to investigate the benefit of early involvement of low-dose radiotherapy(LDRT) and conventionally fractionated radiotherapy(CFRT) in the first-line anti-PD-1 based treatment of metastatic ESCC. It begins with a safet…
Phase: PHASE2 • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Gene therapy for hemophilia a: how long does it last?
Disease control ENROLLING_BY_INVITATIONThe BMN 270 clinical development program consists of multiple interventional studies designed to assess the safety and efficacy of a single infusion of BMN 270 for at least 5 years post-infusion. This long-term follow-up study is needed to help further understand the long-term sa…
Sponsor: BioMarin Pharmaceutical • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New combo therapy aims to shrink rectal tumors and save sphincters
Disease control CompletedThe purpose of this study was to evaluate the effect of capecitabine-based long-term radiotherapy followed by 3 cycles Sintilimab (PD-1 inhibitor) in patients with locally advanced rectal cancer.
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Personalized blood thinners could cut stroke risk
Disease control Completed1. Main objective: To explore the efficacy of precise antiplatelet therapy guided by platelet aggregation function in reducing the incidence of 30 day platelet hyperresponsiveness in patients with non-cardiogenic ischemic stroke. 2. Secondary objective: To explore the efficacy an…
Phase: PHASE4 • Sponsor: Sichuan Provincial People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a drug that targets the brain's hunger pathway help people with Bardet-Biedl syndrome?
Disease control Recruiting nowBardet-Biedl syndrome (BBS) and other rare disorders associated with impairment of the melanocortin-4 receptor (MC4R) pathway are characterized by severe early-onset obesity, hyperphagia, and substantial morbidity. Setmelanotide, an MC4R agonist, is approved in Europe for selecte…
Phase: PHASE4 • Sponsor: Tom Hühne • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Magic mushroom therapy tested for veteran PTSD
Symptom relief OngoingThe primary aim of this study is to assess the safety and efficacy of psilocybin-assisted therapy in the treatment of post-traumatic stress disorder in United States military Veterans.
Phase: PHASE2 • Sponsor: Ohio State University • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC